Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$20.67 - $40.33 $2.35 Million - $4.58 Million
-113,658 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$36.68 - $54.02 $1.23 Million - $1.81 Million
33,450 Added 41.7%
113,658 $4.5 Million
Q3 2021

Nov 15, 2021

BUY
$49.57 - $58.15 $67,910 - $79,665
1,370 Added 1.74%
80,208 $4.01 Million
Q2 2021

Aug 16, 2021

BUY
$47.17 - $58.64 $142,547 - $177,210
3,022 Added 3.99%
78,838 $4.38 Million
Q1 2021

May 13, 2021

BUY
$42.51 - $54.07 $480,788 - $611,531
11,310 Added 17.53%
75,816 $3.55 Million
Q4 2020

Feb 16, 2021

SELL
$31.9 - $44.89 $1.43 Million - $2.01 Million
-44,821 Reduced 41.0%
64,506 $2.81 Million
Q3 2020

Nov 16, 2020

BUY
$28.55 - $36.91 $432,361 - $558,965
15,144 Added 16.08%
109,327 $4 Million
Q2 2020

Aug 13, 2020

BUY
$24.0 - $32.87 $2.26 Million - $3.1 Million
94,183 New
94,183 $2.75 Million

Others Institutions Holding HCAT

About Health Catalyst, Inc.


  • Ticker HCAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 54,723,400
  • Market Cap $403M
  • Description
  • Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...
More about HCAT
Track This Portfolio

Track Advantage Alpha Capital Partners LP Portfolio

Follow Advantage Alpha Capital Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advantage Alpha Capital Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Advantage Alpha Capital Partners LP with notifications on news.